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journa l homepage: www.e lsev ier .com/ locate / i j idIn developed countries, 5–10% of hospitalized patients encoun-
ter an infection thatwas not present or incubating upon admission.
It is common opinion that this infection rate can be reduced
signiﬁcantly (ranging between 20% and 30%) if all the medical,
administrative, and logistic components of the healthcare facility
jointly share this objective. Nevertheless, experts and authors of
prevention and treatment guidelines have cautioned that nosoco-
mial infections are not universally preventable or can be prevented
by using different infection control strategies.
The body of research that supports horizontal versus vertical
evidence-based prevention is far from complete and recommenda-
tions rely heavily on expert consensus. Clinical trials on prevention
and treatment are often based on the experience of single centers.
They aremostly carriedout in countries ofhigh income resource and
are limited to a reduced number of enrolled patients, sometimes
excluding the most vulnerable patients in whom the etiology of
nosocomial infection is complex and multi-factorial. This multi-
society position paper on the prevention and management of
nosocomial and severe infections serves the following purposes:
First, the paper formally refutes the idea that nosocomial infections
may not be preventable using both antibiotic and non-antibiotic
strategies. Second, it can serve as a guidance document for hospital
healthcare workers, both physicians and/or nurses, faced with legal* Corresponding author. Tel.: +39 06 55170700; fax: +39 06 5594283.
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doi:10.1016/j.ijid.2010.06.001challenges related to the occurrence of nosocomial severe infections
in their patients. Finally, by linking the existing evidence to its
supportive statements and acknowledging where the evidence is
limited, the paper identiﬁes the gaps in our current knowledge base
and provides direction for future research.
The Italian Society for Infectious Diseases, the Italian Multidis-
ciplinary Society of Hospital Infections, the Italian Society of
Chemotherapy, the Italian Society of Respiratory Medicine, the
Italian Society of Clinical Microbiology, and the Italian Society of
Microbiology:
Sharea commonvisionof an Italianhealthcare systemasamodel
of innovation and sustainable living that creates new life-
supportingopportunities for Italian patients all over the country;
Are committed to leading the world in sustainable healthcare
management, and procuring the best beneﬁts for our patients;
Recognize the similar healthcare challenges that we all face—
now and in the future;
Desire, therefore, multidisciplinary integration of research,
infection control, and clinical management of patients with
nosocomial infections by maximizing the impact of our
individual and joint actions;
Seek to reduce overlap and duplication of effort to minimize
resource demands in developing initiatives in order to achieve
shared objectives;
Embrace a common commitment to maximize and coordinate
intervention strategies in the epidemiological, research, andses. Published by Elsevier Ltd. All rights reserved.
G. Ippolito et al. / International Journal of Infectious Diseases 14S4 (2010) S93–S94S94clinical aspects of infection control and clinical management of
patients affected by nosocomial infections, in order to improve
the quality of life and health of Italian in-patients and out-
patients. From this perspective, continuing medical education
plays a pivotal role in the prevention and treatment of
nosocomial infections using standard and innovative educa-
tional models in acute care, hospital, long-term care, and
nursing home settings;
Celebrate cultural diversity and the greatest resources in
meeting research challenges and clinical opportunities as an
equity objective for Italian patients all over the country;
Endorse the following statements to apply to the healthcare
system nationwide:
1. There is a need for a new integratedmultidisciplinarymodel to
face the emerging and re-emerging outbreak of nosocomial
infections. All healthcare professionals, especially infectious
diseases specialists, need to be involved in this ﬁght against
nosocomial infections.
2. The university core curriculum of medical colleges and all
specialization courses need to address the basic principles of
infection control and clinical management of patients affected,
or likely to be affected, by nosocomial disease in their training
programs.
3. The specialization courses in infectious diseases of the medical
colleges need to be fully oriented towards the comprehensive
knowledge of the basic and advanced principles of infection
control and clinical management of patients affected, or likely
to be affected, by nosocomial infectious diseases.
4. In each hospital setting, infectious disease professionals are
needed as healthcare workers devoted to infection control and
clinical management of patients affected, or likely to be
affected, by nosocomial infectious diseases.
5. Each hospital setting needs an infection control committee and
respective thematic working groups with yearly objectives and
periodic internal and external quality assessments.
6. The infection controlmeasures applied to the different hospital
settings need to be periodically veriﬁed by using process and
outcome indicators, such as infection rate reduction in the
incidence of nosocomial infections and in clinical endpoints
(in-hospital, 30-day, 1-year mortality, etc.).
7. Each hospital setting needs infection control, evidence-based
and locally-adapted protocols, operative procedures and
guidelines on the more common issues of prevention andtreatment (peri-operative antibiotic prophylaxis, pressure
ulcer, and antibiotic prescription control, among others) and
onmedical device indications and use (central venous catheter
management, urinary catheter use, etc.).
8. A regional plan to ﬁght the occurrence of emerging and re-
emerging outbreaks of nosocomial infections in acute-care and
long-term care facilities needs to be jointly promoted by the
regional health authority, the national authorities, and the
local infectious disease professionals.
9. Since decreasing community use of antibiotics is an important
strategy for combating the increase in community-acquired
antibiotic-resistant infections, the panel recommends devel-
oping a series on ‘‘The principles of appropriate antibiotic use’’.
10. Regarding the problem of bacterial antimicrobial resistance,
the panel recommends the following principles:
a. To establish a system formonitoring bacterial resistance and
antibiotic use;
b. To adopt the validated – national or international –
recommendations, such as the Centers for Disease Control
and Prevention’s ‘‘Guidelines for isolation precautions in
hospitals’’, as a referral standard for the isolation of patients
colonized or infected with resistant microorganisms;
c. To evaluate the effectiveness of the adopted policies.
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